STAT+: STAT+ Conversation: Blueprint for cancer drugs

Off Biotech, cancer, drug development, Health, Human Health, Life Sciences, Medicine, Pharmaceuticals, Science and Research, STAT+ Conversations

Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET.

Every week, week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT general assignment reporter and associate editorial director of events Nicholas St. Fleur will be joined by Fouad Namouni, president of research and development at Blueprint Medicines. They will be discussing Blueprint’s work in making targeted cancer drugs, the future of oncology, and of course be taking your questions live.

Continue to STAT+ to read the full story…

Read Original Article: STAT+: STAT+ Conversation: Blueprint for cancer drugs »

About The Author